SCHEMBL5136202

SCHEMBL5136202

CS(=O)(=O)n1cnc2c(N)nc3ccccc3c21

nearest known ligand 0.55

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 16/20 0.55
ADORA2A P29274 3/20 0.55
LMNA P02545 1/20 0.55
POLB P06746 1/20 0.55
HRH2 P25021 1/20 0.55
ADRA1D P25100 1/20 0.55
HTR2A P28223 1/20 0.55
ADRA1A P35348 1/20 0.55
NUDT1 P36639 1/20 0.55
HTR2B P41595 1/20 0.55
PDE4D Q08499 1/20 0.55
KCNH2 Q12809 1/20 0.55
TLR8 Q9NR97 6/20 0.40
ADORA3 P0DMS8 2/20 0.40
ADORA1 P30542 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7102791 0.89 TLR7 (0.54) TLR7ADORA2ALMNAPOLBHRH2
SCHEMBL3183969 0.78 TLR7 (0.62) TLR7ADORA2ALMNAPOLBHRH2
SCHEMBL8723784 0.77 TLR7 (0.62) TLR7ADORA2ALMNAPOLBHRH2
SCHEMBL5370008 0.76 TLR7 (0.60) TLR7ADORA2ALMNAPOLBHRH2
SCHEMBL4753594 0.76 TLR7 (0.59) TLR7ADORA2ALMNAPOLBHRH2
SCHEMBL5358343 0.75 TLR7 (0.59) TLR7ADORA2ALMNAPOLBHRH2
SCHEMBL6030934 0.75 TLR7 (0.59) TLR7ADORA2ALMNAPOLBHRH2
Imiquimod SCHEMBL9602249 0.74 TLR7 (0.82) TLR7ADORA2ALMNAPOLBHRH2
SCHEMBL1893718 0.74 TLR7 (0.58) TLR7ADORA2ALMNAPOLBHRH2
SCHEMBL13770893 0.74 TLR7 (0.65) TLR7ADORA2ALMNAPOLBHRH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1948173-A2 HYDROXY AND ALKOXY SUBSTITUTED 1H-IMIDAZOQUINOLINES AND METHODS Coley Pharmaceutical Group, Inc. (US) 2008-07-30 EP disclosed
WO-2007056112-A2 HYDROXY AND ALKOXY SUBSTITUTED 1H-IMIDAZOQUINOLINES AND METHODS COLEY PHARMACEUTICAL GROUP, INC. (US) 2007-05-18 WO disclosed